品牌价值网_中国品牌价值排行榜-Goldman Sachs Says AI Might Impact 300 Million Jobs Globally
中国品牌价值评价标准

当前位置:首页 > 国际动态>正文

Goldman Sachs Says AI Might Impact 300 Million Jobs Globally

2023-04-11 18:09:40    来源:www.bvrcn.com 品牌价值网

On March 26, 2023, Goldman Sachs released a report that said that AI might impact 300 million jobs globally because artificial intelligence has spawned platforms like ChatGPT that can automate jobs worldwide. According to the report, 18% of work globally could be computerized. The bank also estimated that in the United States and Europe, approximately two-thirds of current jobs were under the influence of some degree of AI automation and up to a quarter of all work could be done by AI completely. As a matter of fact, the report predicted that 7% of current US employment can be substituted by AI. At greatest risk of becoming replaced by AI are administrative and legal professions compared to the “little effect” seen on physically demanding or outdoor occupations, such as construction and repair work.


          According to Brand Value (China) Network, we don’t need to worry about that AI can increase unemployment because the net number of jobs will not decrease. This is because we need to pay for the severs, processing units and data warehouse, and plenty of money and human resources to run these AI-related platforms. At the same time, AI does mean more competition, more startups, and faster pace. AI can work alongside humans, not just a tool for us but a tool that can use other tools.


1681207651609045.png

According to Brand Value (China) Network, Open AI, Microsoft and Google are pioneering companies for developing companies. Other brand companies such as IBM, Amazon, Chinese Baidu and Tencent are also working on similar AI technologies because AI can make our work more productive and eliminate the grunt work. In the future, we may work four days a week and have a three-day weekend so that we can have more time to express ourselves in our humanityour hobbies or passions.

Goldman Sachs is an American multinational investment bank and financial services company. Founded in 1869, Goldman Sachs is headquartered at 200 West Street in Lower Manhattan,with regional headquarters in London, Warsaw, Bangalore, Hong Kong, Tokyo, Dallas and Salt Lake City, and additional offices in other international financial centers. Goldman Sachs is the second largest investment bank in the world by revenue. In 1994, Goldman Sachs opened its first office in Beijing and a second office in Shanghai. In August 1994, the People’s Bank of China granted Goldman Sachs a special seat in the Shanghai Stock Exchange with a license to trade B share issues reserved for foreign investors. In 2004, the firm established a joint venture in China known as Goldman Sachs Gao Hua Securities Company Limited.

According to China Brand Value Evaluation Standard, the Goldman Sachs Group, Inc. is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to clients that include corporations, financial institutions, governments and individuals. With Gao Hua Joint Venture in 2004, Goldman Sachs established a strong local reputation in the Chinese market.

On the ranking of “The 3rd Daguan·Keweiwei World Brand Value Top 900” released on March 18, 2023, Goldman Sachs Group’s brand value was  845.569 billion RMB, ranking the 10th. Google’s brand value was  1857.905 billion RMB, ranking the 2nd. Amazon’s brand value was 1837.166 billion RMB, ranking the 3rd. Google’s brand value was 1857.905 billion RMB, ranking the 2nd. Amazon’s brand value was 1837.166 billion RMB, ranking the 3rd. Microsoft’s brand value was 1767.582 billion RMB, ranking the 4th.Tencent’s brand value was 780.082 billion, ranking the 12th. Baidu’s brand value was 78.278 billion RMB,ranking the 357th.


品牌热点.png

www.bvrcn.com 品牌价值网

作者:杨瑞安



相关新闻全部阅读

阅读下一篇

新药获批在即,阿斯利康、赛诺菲与Sobi更新合作协议

据外媒消息,医药公司阿斯利康(AstraZeneca)、赛诺菲(Sanofi)与Swedish Orphan Biovitrum (Sobi)于近日更新了其合作协议,以简化RSV 抗体交易合作方式和利润分成。阿斯利康和赛诺菲的呼吸道合胞病毒预防抗体 nirsevimab在欧洲获批,很可能在今年获得美国FDA的批准,Sobi 已与赛诺菲就 nirsevimab 在美国的销售签署了一项新的特许权使用费协议。

返回首页
返回新闻页面